NHMS
LEadership team
The New Horizon Medical Solutions leadership team brings decades of global healthcare, medical device, and life sciences experience. Combining clinical insight, operational expertise, and bold innovation to drive real-world patient outcomes.
Together, they’re building a smarter, stronger future for wound care — one patient, one breakthrough, one horizon at a time.
WHO WE ARE
BUILT BY INDUSTRY VETERANS
The leadership team at New Horizon Medical Solutions brings together executives with deep experience across medical devices, biotech, regenerative medicine, finance, and operations. Our leaders have built and scaled organizations at Stryker, Boston Scientific, Zimmer Biomet, KCI/3M, Pfizer, Allergan, IBM, and beyond — and now apply that experience to advancing wound care.
Every decision, strategy, and product we deliver is guided by this team’s commitment to clinicians, patients, and the standard of care.
WHY IT MATTERS
DRIVING THE FUTURE OF WOUND CARE
Our executive team sets the strategy, builds the operations, and drives the growth that's reshaping how wound care is delivered.
SETTING STRATEGIC DIRECTION
DRIVING OPERATIONAL EXCELLENCE
SCALING COMMERCIAL GROWTH
UPHOLDING COMPLIANCE & QUALITY
GLOBAL EXPERTISE. RELENTLESS FOCUS. REAL IMPACT.
MEET THE TEAM
The New Horizon leadership team combines decades of medical device, healthcare, finance, legal, and operational experience. Each member brings perspective from world-class organizations and applies it to a singular focus: delivering the products, training, and support that today’s wound care providers need.
Will Hall 
Founder & Chief Executive Officer
William Hall is the Founder and CEO of New Horizon Medical Solutions, headquartered in Las Vegas, Nevada. Since launching the company in 2022, he has built New Horizon into a rapidly growing national wound care platform delivering advanced products, medical devices, and integrated billing and managed services.
Earlier in his career, William lived and worked in Australia with Carl Zeiss Meditec Surgical Ophthalmology and Stryker Orthopedics Australia. He later held U.S.-based roles with global medtech leaders including Zimmer Biomet, Boston Scientific, and Hologic, gaining broad clinical and commercial experience across orthopedics, podiatry, and procedural medicine. His work at BioTissue immediately before founding New Horizon helped shape the company's strong focus on regenerative medicine and physician-centered solutions.
Under William's leadership, New Horizon has achieved major milestones including the launch of proprietary amniotic graft technologies, expansion to all 50 states, and the addition of next-generation wound care adjuncts such as NPWT and advanced perfusion imaging.
Ian Wilson Chief Operating Officer
Ian Wilson is a seasoned operational leader with deep experience scaling healthcare enterprises, optimizing organizational performance, and strengthening operational execution across product, service, and market channels. As Chief Operating Officer at New Horizon Medical Solutions, Ian drives operational excellence, advances cross-functional capabilities, and enables the company's strategic expansion in the advanced wound care market.
Ian leads dynamic teams across operations, customer success, billing and optimization, and supply chain — fostering a culture of performance, accountability, and continuous improvement. His leadership directly supports reliable delivery, streamlined workflows, and superior partner experiences. He has played a central role in shaping the company's operational framework, aligning internal systems with market demands, and enhancing organizational agility as New Horizon scales.
Before joining New Horizon, Ian built a track record of enhancing operational performance in complex commercial environments, with leadership roles overseeing diversified teams and driving initiatives that improved efficiency, responsiveness, and client satisfaction. Known for balancing tactical execution with long-term planning, Ian brings a disciplined operational mindset to scaling a fast-growing healthcare solutions company.
Christine Grogan, DHA, MHA, MS Chief Commercial Officer
Christine Grogan, DHA, MHA, MS, is the Chief Commercial Officer at New Horizon Medical Solutions. She is a healthcare commercial executive with more than 25 years of experience at companies such as KCI/3M, Pfizer, Allergan, and several startups. In her most recent role prior to joining New Horizon, Christine served as SVP and General Manager, head of Clinical and Institutional Sales at Avadim, was a member of Avadim's board of directors, and served as president of Engineered Tissue Solutions wound care for the United States.
Christine holds a bachelor's degree in neuroscience from the University of Florida, a master's degree in health science from Nova Southeastern University, an MBA from Nova Southeastern University, a master's degree in healthcare leadership from Brown University, and a doctorate in health administration from the Medical University of South Carolina. She is a member of the American College of Healthcare Executives and the founder of BRAVEcoalition.org. She is also involved with multiple nonprofit organizations focused on addressing healthcare disparities. Christine is a certified yoga instructor and has completed the Yoga Mental Health Certification Program at Stanford University
Danny Bazan Chief Financial Officer
Danny A. Bazan, CPA, is an accomplished chief financial officer with more than two decades of experience leading finance, strategy, and operational transformation for growth-oriented healthcare, life sciences, and global operating companies. He is recognized for building institutional-grade financial organizations, strengthening governance, and serving as a strategic partner to executive leadership, boards, and investment sponsors.
At New Horizon Medical Solutions, Danny oversees financial strategy, capital planning, enterprise systems, and operational controls — with responsibility for audit readiness, investor reporting, and healthcare-specific compliance. He plays a central role in supporting M&A execution, post-acquisition integration, and long-term value creation across multiple business verticals.
Throughout his career, Danny has led finance functions across private equity-backed and multinational organizations operating in complex, multi-entity and regulated environments. His experience spans financial planning and analysis, liquidity and cash-flow management, capital structure support, enterprise ERP implementations, and performance management. Danny holds a Bachelor of Arts in Accounting and Finance from Texas Tech University and is a certified public accountant (CPA).
Bart Verdirame General Counsel
Bart J. Verdirame serves as General Counsel for New Horizon Medical Solutions, responsible for overseeing the legal, regulatory and compliance, and human resources departments across the organization. Bart has more than 25 years of experience serving in corporate legal departments in both the technology and healthcare sectors. He prides himself on partnering with executives to fulfill corporate objectives, mitigate risk, and maintain compliance across all business units.
Prior to joining New Horizon, Bart served as General Counsel for Integrated Practice Solutions and Tririga, in addition to serving as counsel at IBM. He has a proven track record of effectively representing businesses across general legal and strategic advice, corporate compliance and governance, healthcare and regulatory compliance, contract drafting and negotiations, mergers and acquisitions, licensing, partnerships, and employment matters.
Bart earned his law degree from the University of Pennsylvania Law School, where he served on the Law Review editorial board, and received his undergraduate degree from The University of North Carolina at Chapel Hill.
Rob Bergman SVP, Sales
Rob Bergman is a tenured healthcare executive with extensive experience in medical sales leadership. He excels at building high-performance sales teams and forging strategic partnerships to drive revenue growth and market penetration for New Horizon Medical Solutions. As SVP of Sales, Rob leads the sales team and distribution partners to accelerate adoption and expansion of the NHMS product portfolio across biologics, NPWT, capital equipment, advanced wound care solutions, and regenerative technologies, while sitting on the leadership team to help drive the strategic direction of the organization.
Prior to joining New Horizon, Rob served as Corporate Account Director at Cepheid, a Danaher Corporation company, where he established pricing strategies, developed sales programs, and aligned senior leadership to drive sales growth through large distribution channel partners across the United States.
Before Cepheid, Rob spent 20 years with Integra LifeSciences at Miltex Instruments, advancing through a series of key leadership roles. He began as Southeast Regional Sales Director, then served as Director of Surgery Centers, before being appointed Director of Sales for the US & Canada — a role he held for 11 years. During this time, he built and led the sales organization to consistent performance and expansion across both markets. Earlier in his career, Rob was a Regional Sales Manager at Spacelabs Burdick, a company specializing in cardiology diagnostic solutions. Rob resides in Tampa, Florida with his wife and son.
Charles Hall Strategic Advisor to CEO
Charles Hall is a foundational member of New Horizon Medical Solutions and serves as a Strategic Advisor to the CEO, bringing more than three decades of global leadership experience in the medical device industry.
Charles began his career in the early 1990s in Australia, transitioning into medical devices after a successful period as a professional basketball player. He entered the industry with Stryker Australia, laying the foundation for what has become a distinguished career spanning over 30 years. Throughout his career, Charles has held a broad range of senior leadership positions, including Sales Representative, State Manager, Regional Manager, Sales Director, National Sales Manager, Director of Business Development, and Principal Distributor. His professional journey has spanned Australia, New Zealand, and the United States, providing deep international market insight and operational expertise.
Charles has developed extensive experience across multiple surgical disciplines including orthopaedics, pain management, consumables, and capital equipment. He has worked with several of the world's leading medical technology companies including Stryker, Synthes, DePuy, Zimmer Biomet, ZEISS, and DJO.
Raymond Jessen SVP, Compliance, Regulatory Affairs & Quality
Raymond Jessen, MPH, MHSA, CTBS, is a healthcare executive with more than 25 years of experience leading regulatory strategy, quality, and compliance across medical devices, human cell, tissue, and cellular and tissue-based products (HCT/Ps), pharmaceuticals, and integrated healthcare systems.
As SVP of Compliance, Regulatory Affairs & Quality at New Horizon Medical Solutions, Raymond oversees regulatory strategy, the quality system, and compliance infrastructure — with responsibility for inspection readiness, product lifecycle planning, risk mitigation, and scalable quality operations. He plays a central role in supporting new product development, commercialization, and organizational transformation as the company scales.
Throughout his career, Raymond has led both domestic and global regulatory and quality initiatives at organizations including Intermountain Health, Smith & Nephew, PolarityBio, Genpact, the University of Utah's Utah Lions Eye Bank, and The North Carolina Eye Bank (now part of Precision Ocular Network) — supporting thousands of regulatory submissions and advancing high-reliability organization (HRO) principles. He holds an MPH and MHSA from the University of Utah School of Medicine and is a Certified Tissue Bank Specialist (CTBS).
Stuart Porteous Chief of Staff
Stuart Porteous is Chief of Staff at New Horizon Medical Solutions, where his role centers on helping the organization work well as it continues to evolve. He partners with the CEO, leadership team, and functional groups to bring clarity to priorities, support collaboration, and ensure that day-to-day execution reflects the company's longer-term goals.
Since joining New Horizon in 2024, Stuart has held several roles focused on building structure during a period of rapid growth. Beginning as Chief Process Officer, he helped establish core operating foundations before moving into Vice President of Business Operations, supporting teams across account management, logistics, contracts, sales, and revenue operations. He was later appointed Chief of Staff to help strengthen execution and leadership effectiveness across the company.
Before transitioning into healthcare, Stuart spent 18 years working across the global oil and gas and renewable energy sectors, holding senior roles across technical, project, and commercial functions. In 2020, he relocated from the United Kingdom to the United States — prompted, as he often notes, by a firm household mandate driven by his Vegas-born wife's limited tolerance for British weather.
Chris Bauer SVP, Strategy & Market Commercialization
Chris Bauer is a commercial executive with more than 25 years of experience driving growth across medical devices, biologics, wound care, healthcare logistics, and consumer health. He has a proven track record of scaling start-ups to acquisition, revitalizing global brands, and leading cross-functional teams in highly regulated markets.
As SVP of Strategy & Market Commercialization at New Horizon Medical Solutions, Chris leads upstream business, product, and market development — with the goal of transforming New Horizon into a market-leading continuum-of-care wound care company. He partners across marketing, sales, business development, and finance to align commercial strategy with the company's long-term growth objectives.
Most recently, Chris served as VP of Sales & Marketing at NeXtgen Biologics. Earlier in his career, he held senior commercial and marketing leadership roles at 3M, KCI, Crawford Healthcare, Convatec, and Johnson & Johnson, where he built and revitalized leading brands in advanced wound care and consumer health. Chris holds an MBA in Marketing from the University of North Carolina at Chapel Hill and a Bachelor of Science in Marketing from Clemson University. He resides outside Philadelphia with his family.
Naz Wahab, MD, FAAFP, FAPWCA Medical Director
Naz A. Wahab, MD, FAAFP, FAPWCA, is a highly respected wound care expert and board-certified family physician based in Las Vegas, Nevada. With more than two decades of clinical experience, Dr. Wahab has dedicated her career to the diagnosis, management and advanced treatment of complex and chronic wounds. She is the Founder and Medical Director of Wound Care Experts in Las Vegas and serves as Medical Director of both outpatient and inpatient wound care and hyperbaric medicine programs, including for Dignity Health hospitals and Mountain View Hospital’s Wound Care & Hyperbaric Center.
Dr. Wahab holds board certification in family medicine and specialized certification in wound care and hyperbaric medicine. She is a Fellow of the American Professional Wound Care Association and an active member and past board officer of several leading wound care organizations, including the Association for the Advancement of Wound Care and the Alliance of Wound Care Stakeholders. A committed educator and researcher, Dr. Wahab directs clinical research initiatives, serves as adjunct faculty at Touro University Nevada College of Osteopathic Medicine, and contributes to continuing education programs for healthcare professionals in wound healing.
JOIN OUR TEAM
Build the Future of Wound Care With Us
We’re growing fast — and looking for clinicians, sales professionals, and operational leaders who share our commitment to advancing wound care.